015 USA
Made in Germany
Distributed by:
Bristol-Myers Squibb Company
Princeton, NJ 08543 USA
1252629A2
5643-8002
Rev March 2011
---------------------------------------------
REPRESENTATIVE PACKAGING
See How Supplied section for a complete list of available packages of Etopophos.
NDC 0015-3404-20
Single-Dose Vial
Etopophos® (etoposide phosphate) for Injection
For IV use
Etoposide phosphate equivalant to
100 mg etoposide
Rx only
Etopophos
etoposide phosphate injection, powder, lyophilized, for solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:0015-3404
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
etoposide phosphate (etoposide) etoposide 100 mg
Inactive Ingredients
Ingredient Name Strength
sodium citrate 32.7 mg
dextran 40 300 mg
Packaging
Item Code Package Description
1 NDC:0015-3404-20 1 VIAL, SINGLE-DOSE (1 VIAL) in 1 CARTON
1 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (1 VIAL) in 1 VIAL, SINGLE-DOSE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA020457 06/01/2009
Labeler - E.R. Squibb & Sons, L.L.C. (968242821)
Revised: 03/2011
|
